Rampart Health, L.L.C.   Report issue

For profit Phase 2
Founded: Orlando FL United States (2018)

Organization Overview

First Clinical Trial
2019
NCT04090775
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Rampart Health | Rampart Health, L.L.C.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 5